Glander P - Search Results

1

Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?

Fleiner F, Fritsche L, Glander P, Neumayer HH, Budde K. Fleiner F, et al. Among authors: glander p. Transplantation. 2006 Mar 15;81(5):655-9. doi: 10.1097/01.tp.0000214933.73927.4e. Transplantation. 2006. PMID: 16534464

2

Pharmacodynamic monitoring of mycophenolate mofetil.

Budde K, Glander P, Bauer S, Braun K, Waiser J, Fritsche L, Mai I, Roots I, Neumayer HH. Budde K, et al. Among authors: glander p. Clin Chem Lab Med. 2000 Nov;38(11):1213-6. doi: 10.1515/CCLM.2000.191. Clin Chem Lab Med. 2000. PMID: 11156363

3

Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.

Glander P, Braun KP, Hambach P, Bauer S, Mai I, Roots I, Waiser J, Fritsche L, Neumayer HH, Budde K. Glander P, et al. Clin Biochem. 2001 Oct;34(7):543-9. doi: 10.1016/s0009-9120(01)00267-3. Clin Biochem. 2001. PMID: 11738390

4

Pharmacodynamic monitoring of mycophenolate mofetil in renal allograft recipients.

Budde K, Glander P, Braun KP, Böhler T, Waiser J, Fritsche L, Mai I, Neumayer H. Budde K, et al. Among authors: glander p. Transplant Proc. 2001 Nov-Dec;33(7-8):3313-5. doi: 10.1016/s0041-1345(01)02407-1. Transplant Proc. 2001. PMID: 11750418 No abstract available.

5

Pharmacokinetics and pharmacodynamics of mycophenolate mofetil under oral and intravenous therapy.

Braun KP, Glander P, Hambach P, Böhler T, Waiser J, Mai I, Neumayer HH, Budde K. Braun KP, et al. Among authors: glander p. Transplant Proc. 2002 Aug;34(5):1745-7. doi: 10.1016/s0041-1345(02)03051-8. Transplant Proc. 2002. PMID: 12176560 No abstract available.

6

Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients.

Budde K, Braun KP, Glander P, Böhler T, Hambach P, Fritsche L, Waiser J, Mai I, Neumayer HH. Budde K, et al. Among authors: glander p. Transplant Proc. 2002 Aug;34(5):1748-50. doi: 10.1016/s0041-1345(02)03052-x. Transplant Proc. 2002. PMID: 12176561 No abstract available.

7

Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.

Glander P, Hambach P, Braun KP, Fritsche L, Waiser J, Mai I, Neumayer HH, Budde K. Glander P, et al. Int J Clin Pharmacol Ther. 2003 Oct;41(10):470-6. doi: 10.5414/cpp41470. Int J Clin Pharmacol Ther. 2003. PMID: 14703953 Clinical Trial.

8

Cyclosporin C2hour monitoring after renal transplantation.

Einecke G, Mai I, Fritsche L, Slowinski T, Waiser J, Glander P, Böhler T, Neumayer HH, Budde K. Einecke G, et al. Among authors: glander p. Int J Clin Pharmacol Ther. 2003 Oct;41(10):477-81. doi: 10.5414/cpp41477. Int J Clin Pharmacol Ther. 2003. PMID: 14703954

9

Treating type 2 diabetes in renal insufficiency: the role of pioglitazone.

Fritsche L, Budde K, Glander P, Einecke G, Diekmann F, Schötschel R, Neumayer HH. Fritsche L, et al. Among authors: glander p. Int J Clin Pharmacol Ther. 2003 Oct;41(10):488-91. doi: 10.5414/cpp41488. Int J Clin Pharmacol Ther. 2003. PMID: 14703956 Review.

10

Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.

Budde K, Glander P, Diekmann F, Dragun D, Waiser J, Fritsche L, Neumayer HH. Budde K, et al. Among authors: glander p. Transplant Proc. 2004 Mar;36(2 Suppl):524S-527S. doi: 10.1016/j.transproceed.2003.12.042. Transplant Proc. 2004. PMID: 15041401 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters